55. Dai NT, Chen TM, Cheng TY, et al. The comparison of early fluid therapy in extensive flame burns

between inhalation and noninhalation injuries. Burns 1998;24:671–675.

56. Schiller WR, Bay RC. Hemodynamic and oxygen transport monitoring in management of burns.

New Horiz 1996;4:475–482.

57. Lorente JA, Ezpeleta A, Esteban A, et al. Systemic hemodynamics, gastric intramucosal PCO2

changes, and outcome in critically ill burn patients. Crit Care Med 2000;28:1728–1735.

58. Holm C, Melcer B, Horbrand F, et al. Haemodynamic and oxygen transport responses in survivors

and non-survivors following thermal injury. Burns 2000;26:25–33.

59. Kashefi NS, Nathan JI, Dissanaike S. Does a nebulized heparin/N-acetylcysteine protocol improve

outcomes in adult smoke inhalation? Plast Reconstr Surg Glob Open 2014;2:e165.

60. Miller AC, Rivero A, Ziad S, et al. Influence of nebulized unfractionated heparin and Nacetylcysteine in acute lung injury after smoke inhalation injury. J Burn Care Res 2009;30:249–256.

61. Palmieri TL, Enkhbaatar P, Bayliss R, et al. Continuous nebulized albuterol attenuates acute lung

injury in an ovine model of combined burn and smoke inhalation. Crit Care Med 2006;34:1719–

1724.

62. Salman D, Finney SJ, Griffiths MJ. Strategies to reduce ventilator-associated lung injury (VALI).

Burns 2013;39:200–211.

63. Peck MD, Koppelman T. Low-tidal-volume ventilation as a strategy to reduce ventilator-associated

injury in ALI and ARDS. J Burn Care Res 2009;30:172–175.

64. Chung KK, Wolf SE, Renz EM, et al. High-frequency percussive ventilation and low tidal volume

ventilation in burns: a randomized controlled trial. Crit Care Med 2010;38:1970–1977.

65. Mosier MJ, Pham TN. American Burn Association Practice guidelines for prevention, diagnosis, and

treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res 2009;30:910–

928.

66. Herndon DN, Barrow RE, Stein M, et al. Increased mortality with intravenous supplemental feeding

in severely burned patients. J Burn Care Rehabil 1989;10:309–313.

67. Herndon DN, Hart DW, Wolf SE, et al. Reversal of catabolism by beta-blockade after severe burns.

N Engl J Med 2001;345:1223–1229.

68. Hemmila MR, Taddonio MA, Arbabi S, et al. Intensive insulin therapy is associated with reduced

infectious complications in burn patients. Surgery 2008;144(4):629–635.

69. Atiyeh BS, Costagliola M, Hayek SN, et al. Review effect of silver on burn wound infection control

and healing: review of the literature. Burns 2007;33:139–148.

70. Falcone PA, Harrison HN, Sowemimo GO, et al. Mafenide acetate concentrations and bacteriostasis

in experimental burn wounds treated with a three-layered laminated mafenide-saline dressing. Ann

Plast Surg 1980;5:226–229.

71. Fong J, Wood F. Nanocrystalline silver dressings in wound management: a review. Nanomedicine

2006;1:441–449.

72. Gravante G, Caruso R, Sorge R, et al. Nanocrystalline silver: a systematic review of randomized

trials conducted on burned patients and an evidence-based assessment of potential advantages over

older silver formulations. Ann Plast Surg 2009;63:201–205.

406

http://surgerybook.net/

73. Engav L, Hiembach D, Reus J, et al. Early excision and grafting vs. nonoperative treatment of burns

of indeterminant depth: a randomized prospective study. J Trauma 1983;23:510–517.

74. Gray D, Pine R, Harnar T, et al. Early surgical excision versus conventional therapy in patients with

20 to 40 percent burns. A comparative study. Am J Surg 1982;144:76–80.

75. Mulholland MW. Greenfield’s Surgery. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

76. Sterling J, Gibran NS, Klein MB. Acute management of hand burns. Hand Clin 2009;25:453–459.

77. Klein MB, Moore ML, Costa B, et al. Primer on the management of face burns at the University of

Washington. J Burn Care Res 2005;26:2–6.

78. Benichou G, Yamada Y, Yun SH, et al. Immune recognition and rejection of allogeneic skin grafts.

Immunotherapy 2011;3:757–770.

79. Ronfard V, Rives JM, Neveux Y, et al. Long-term regeneration of human epidermis on third degree

burns transplanted with autologous cultured epithelium grown on a fibrin matrix. Transplantation

2000;70:1588–1598.

80. Atiyeh BS. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns

2007;33:405–413.

81. Elliott M, Vandervord J. Initial experience with cultured epithelial autografts in massively burnt

patients. ANZ J Surg 2002;72:893–895.

82. Paddle-Ledinek JE, Cruickshank DG, Masterton JP. Skin replacement by cultured keratinocyte

grafts: an Australia experience. Burns 1997;23:204–211.

83. Brown D, Borschel GH. Michigan Manual of Plastic Surgery. Philadelphia, PA: Lippincott Williams &

Wilkins; 2004.

84. O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheterrelated infections. Healthcare Infection Control Practices Advisory Committee. Am J Infect Control

2011;39(4 suppl 1):S1–34. doi:10.1016/j.ajic.2011.01.003

85. Tandara AA, Mustoe TA. The role of the epidermis in the control of scarring: evidence for

mechanism of action for silicone gel. J Plast Reconstr Aesthet Surg 2008;61:1219–1225.

86. Mustoe TA. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic

Plast Surg 2008;32:82–92.

87. Saulis AS, Chao JD, Telser A, et al. Silicone occlusive treatment of hypertrophic scar in the rabbit

model. Aesthet Surg J 2002;22:147–153.

88. Steinstraesser L, Flak E, Witte B, et al. Pressure garment therapy alone and in combination with

silicone for the prevention of hypertrophic scarring: randomized controlled trial with

intraindividual comparison. Plast Reconstr Surg 2011;128:306e–313e.

89. Van den Kerckhove E, Stappaerts K, Fieuws S, et al. The assessment of erythema and thickness on

burn related scars during pressure garment therapy as a preventive measure for hypertrophic

scarring. Burns 2005;31:696–702.

90. Lawrence JW, Mason ST, Schomer K, et al. Epidemiology and impact of scarring after burn injury:

a systematic review of the literature. J Burn Care Res 2012;33:136–146.

91. Gangemi EN, Gregori D, Berchialla P, et al. Epidemiology and risk factors for pathologic scarring

after burn wounds. Arch Facial Plast Surg 2008;10:93–102.

92. Nedelec B, Shankowsky H, Scott PG, et al. Myofibroblasts and apoptosis in human hypertrophic

scars: the effect of interferon-alpha2b. Surgery 2001; 130:798–808.

93. Armour A, Scott PG, Tredget EE. Cellular and molecular pathology of HTS: basis for treatment.

Wound Repair Regen 2007;15:S6–S17.

94. Longacre JJ, Berry HK, Basom CR, et al. The effects of Z plasty on hypertrophic scars. Scand J Plast

Reconstr Surg 1976;10:113–128.

95. Davis JS. The relaxation of scar contractures by means of the Z-, or reversed Z-type incision:

stressing the use of scar infiltrated tissues. Ann Surg 1931;94:871–884.

96. Parnell LK, Nedelec B, Rachelska G, et al. Assessment of pruritus characteristics and impact on burn

survivors. J Burn Care Res 2012;33:407–418.

97. Klinger M, Marazzi M, Vigo D. Fat injection for cases of severe burn outcomes: a new perspective

of scar remodeling and reduction. Aesthetic Plast Surg 2008;32:465–469.

98. Reish RG, Eriksson E. Scar treatments: preclinical and clinical studies. J Am Coll Surg 2008;206:719–

407

http://surgerybook.net/

730.

99. Zouboulis CC, Blume U, Buttner P, et al. Outcomes of cryosurgery in keloids and hypertrophic

scars. A prospective consecutive trial of case series. Arch Dermatol 1993;129:1146–1151.

100. Alster TS, Handrick C. Laser treatment of hypertrophic scars, keloids, and striae. Semin Cutan Med

Surg 2000;19:287–292.

101. Manuskiatti W, Wanitphakdeedecha R, Fitzpatrick RE. Effect of pulse width of a 595-nm flashlamppumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars.

Dermatol Surg 2007;33:152–161.

102. Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect

response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulseddye laser. J Am Acad Dermatol 2001;45:557–565.

103. Garden JM, Tan OT, Kerschmann R, et al. Effect of dye laser pulse duration on selective cutaneous

vascular injury. J Invest Dermatol 1986;87:653–657.

104. Manstein D, Herron GS, Sink RK, et al. Fractional photothermolysis: a new concept for cutaneous

remodeling using microscopic patterns of thermal injury. Laser Surg Med 2004;34:426–438.

105. Gore DC, Chinkes DL, Wolf SE, et al. Quantification of protein metabolism in vivo for skin, wound,

and muscle in severe burn patients. JPEN J Parenter Enteral Nutr 2006;30:331–338.

106. Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response

to severe burn injury. PLoS One 2011;6:e21245.

107. Rutan RL, Herndon DN. Growth delay in postburn pediatric patients. Arch Surg 1990;125:392–395.

108. Tuvdendorj D, Chinkes DL, Zhang XJ, et al. Skeletal muscle is anabolically unresponsive to an

amino acid infusion in pediatric burn patients 6 months postinjury. Ann Surg 2011;253:592–597.

109. Porter C, Cotter M, Diaz EC, et al. Amino acid infusion fails to stimulate skeletal muscle protein

synthesis up to 1 year after injury in children with severe burns. J Trauma Acute Care Surg

2013;74:1480–1485.

110. Padfield KE, Astrakas LG, Zhang Q, et al. Burn injury causes mitochondrial dysfunction in skeletal

muscle. Proc Natl Acad Sci U S A 2005;102:5368–5373.

111. Righi V, Constantinou C, Mintzopoulos D, et al. Mitochondria-targeted antioxidant promotes

recovery of skeletal muscle mitochondrial function after burn trauma assessed by in vivo 31P

nuclear magnetic resonance and electron paramagnetic resonance spectroscopy. FASEB J

2013;27:2521–2530.

112. Cree MG, Zwetsloot JJ, Herndon DN, et al. Insulin sensitivity and mitochondrial function are

improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg

2007;245:214–221.

113. Przkora R, Herndon DN, Suman OE. The effects of oxandrolone and exercise on muscle mass and

function in children with severe burns. Pediatrics 2007;119:e109–e116.

114. Elledge ES, Smith AA, McManus WF, et al. Heterotopic bone formation in burned patients. J

Trauma 1988;28:684–687.

115. Esselman PC, Thombs BD, Magyar-Russell G, et al. Burn rehabilitation: state of the science. Am J

Phys Med Rehabil 2006;85:383–413.

116. Evans EB. Orthopaedic measures in the treatment of severe burns. J Bone Joint Surg Am

1966;48:643–669.

117. Klein MB, Logsetty S, Costa B, et al. Extended time to wound closure is associated with increased

risk of heterotopic ossification of the elbow. J Burn Care Res 2007;28:447–450.

118. Maender C, Sahajpal D, Wright TW. Treatment of heterotopic ossification of the elbow following

burn injury: recommendations for surgical excision and perioperative prophylaxis using radiation

therapy. J Shoulder Elbow Surg 2010;19:1269–1275.

119. Orzel J, Rudd T. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl

Med 1985;26:125–132.

120. Neal B, Rogers A, Clark T, et al. A systematic survey of 13 randomized trials of non-steroidal antiinflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta

Orthop Scand 2000;71:122–128.

121. Fearonce G, Faraklas I, Saffle J, et al. Peripherally inserted central venous catheters and central

venous catheters in burn patients: a comparative review. J Burn Care Res 2010;31:31–35.

408